GLP-1 prescriptions for weight-loss In a separate analysis between 2020 and 2023, one HealthVerity closed claims dataset had more than 1.5 million patients who had at least one prescription for tirzepatide or semaglutide
LVG, IN, AF, AFHP, LC, CWCK, and JLS reviewed the manuscript for important intellectual content
A nomogram to estimate the HbA1c response to different DPP-4 inhibitors in type 2 diabetes: a systematic review and meta-analysis of 98 trials with 24 163 patients
The form takes about 1015 minutes and serves as the foundation for your providers eligibility review
In a future TNG post, contributing writer MacKenzie Isaac, a doctoral student in population health, will cover equity issues surrounding GLP-1 RA access
"It's good news that Medicare is rolling out this program, but it is temporary, so it's really not clear at this point what happens after the end of the 18-month program duration," said Juliette Cubanski, director of the Program on Medicare Policy at KFF, a health policy research organization
